CME developer Accelera to join with Romar Consulting

Share this article:
Interactive CME program developer Accelera has announced that it will "create a unified company" with skills training and facilitated workshops provider Romar Consulting beginning in January 2006.
Financial terms of the deal were not disclosed.
Debbie Ung, president of the Baltimore-based Accelera told MM&M that further details would
not be available until the beginning of 2006.
In January, Accelera became a licensee of Johns Hopkins Medicine International, the organization tasked with sharing Hopkins research, education, and patient care with institutions and physicians.
Accelera and Woodlands, Texasbased Romar are both subsidiaries of the life sciences firm Alpha Genesis, which is headquartered in Washington,D.C.
Share this article:
You must be a registered member of MMM to post a comment.

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...